In OS cells, combined treatment significantly increased the expression of the enzyme sphingosine-1-phosphate lyase (SGPL1) [165], which irreversibly degrades sphingosine-1-phosphate (S1P) and whose production and secretion is associated with an increased capability of migration and invasion of cancer cells [151]. This evidence concerns the gene SGPL1 and cancer.